Linkage disequilibrium characterization of CYP2C and CYP2D genomic regions in European populations

被引:0
|
作者
不详
机构
关键词
ASSOCIATION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:460 / 461
页数:2
相关论文
共 50 条
  • [21] CYP2C18: the orphan in the CYP2C family
    Zubiaur, Pablo
    Gaedigk, Andrea
    PHARMACOGENOMICS, 2022, 23 (16) : 913 - 916
  • [22] Effects of herbalteas on CYP1A, CYP2C and CYP2D-mediated metabolic activities
    Nishimura, Yuki
    Kurata, Norimitsu
    Iwase, Mariko
    Yasuhara, Hajime
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 209P - 209P
  • [23] 黄芪颗粒和黄芪注射液对CYP1A2、CYP2D、CYP2C亚酶活性影响的实验研究
    张咏莉
    崔玉强
    汪向升
    李静清
    陈江英
    中国药理学通报, 2013, 29 (04) : 512 - 519
  • [24] TRANSCRIPTIONAL REGULATION OF HUMAN CYP2C GENES - FUNCTIONAL COMPARISON OF CYP2C9 AND CYP2C18 PROMOTER REGIONS
    IBEANU, GC
    GOLDSTEIN, JA
    BIOCHEMISTRY, 1995, 34 (25) : 8028 - 8036
  • [25] Distribution of a novel CYP2C haplotype in Native American populations
    Fernandes, Vanessa Camara
    Pretti, Marco Antonio M.
    Tsuneto, Luiza Tamie
    Petzl-Erler, Maria Luiza
    Suarez-Kurtz, Guilherme
    FRONTIERS IN GENETICS, 2023, 14
  • [26] Oxidation of debrisoquine by marmoset CYP2D enzymes, CYP2D19 and CYP2D30
    Narimatsu, S
    Kuramoto, S
    Hichiya, H
    Yamamoto, S
    Asaoka, K
    Miyata, A
    Kiryu, K
    Ueda, N
    Naito, S
    Ellis, SW
    DRUG METABOLISM REVIEWS, 2003, 35 : 192 - 192
  • [27] Analyses of CYP2C in Porcine Microsomes
    Skaanild, Mette T.
    Friis, Christian
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 103 (05) : 487 - 492
  • [28] The endogenous substrates of brain CYP2D
    Wang, Xiaoshuang
    Li, Jie
    Dong, Guicheng
    Yue, Jiang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 724 : 211 - 218
  • [29] CYP2D is involved in neurosteroidogenesis in the brain
    Kishimoto, W
    Hiroi, T
    Osada, M
    Imaoka, S
    Igarashi, T
    Fuane, Y
    CYTOCHROMES P450, BIOCHEMISTRY, BIOPHYSICS AND DRUG METABOLISM, 2003, : 223 - 225
  • [30] Polymorphisms in the human CYP2C subfamily
    Goldstein, JA
    DRUG METABOLISM REVIEWS, 2002, 34 : 5 - 5